BioSolveIT

3Scan is turning tissue biology and histopathology into data science, giving researchers the insights they need to break new ground.

A one-stop shop for digital and computational pathology, 3Scan’s KESM produces digital 3D tissue models with micron-scale resolution at 400 times the throughput of traditional microscopes.

3Scan’s data platform enables quantitative image analysis of diseases like cancer, Parkinson’s, Alzheimer’s, and Huntington’s, opening up the potential for new diagnostic and therapeutic solutions.
Founded by Todd Huffman, Megan Klimen, Matthew Goodman, and Cody Daniel in San Francisco in 2011, 3Scan’s team of engineers, biologists and data-scientists is expanding its work into a suite of digital tools that will allow instant identification and classification of histopathologic features and tissue structures.

Agere is a global leader in bioavailability enhancement and cGMP services. Our comprehensive formulation design and development capabilities leverage Agere's Quadrant 2 solubilization formulation platform. Quadrant 2 empowers formulation development to efficiently explore a broader design space. Adhering to quality by design (QbD) guidelines de-risks results to achieve your target product profile.

All client services -- from formulation through clinical trials materials manufacturing -- are customized per API and done on a fee-for-service basis.

Formulation Development
• Formulation design and development
• Solubilization formulation expertise
• Innovative analytical technologies
• Materials science and characterization
• Computational modeling

cGMP Manufacturing
• Spray drying
• Tablets
• Capsules
• Inhalation powders
• Topical dosage forms

cGMP Analytical
• Full support for manufacturing and release testing
• Method development and transfer
• Method qualification/validation
• Full stability suite of services

EMAIL: info@agerepharma.com or careers@agerepharma.com

UNDER CONSTRUCTION - ATG is a synthetic biology and biotech company. We combine proprietary analytical and synthetic bioinformatics tools and expertise with systems for the design, assembly and expression of multi-gene and multi-peptide constructs.
Products and services for drug discovery, industrial and medical biotechnology, molecular diagnostics, and bioengineering.
* Multi-gene recombineering and expression systems for E.coli, insect and mammalian cells (Toggle, MultiLabel)
* Tailor-made expression systems for other (micro)organisms based on a modular assembly strategy (Toggle)
* Proprietary multi-peptide library design tool + biosystems-based multi-peptide library construction and expression system (PepID) for rationally designed bio-peptide libraries. Assess, identify (map) and verify peptide epitopes, antibodies, or protein-protein-interactions in diagnostics and therapy.
* Gene intelligence solution EvoMAG for multi-parametric complex gene / (artificial) combinatorial gene cluster design as well as formal and operational optimization and moldeling of genes, genetic elements and expression cassettes for diverse target/production organisms (e.g. for functional enzyme optimization, metabolic engineering, signal pathway analysis, etc.)
* Gene synthesis of genes and gene clusters
* Plasmid production and purification
* State-of-the-art computational biology solutions / analysis for immunomics, metabolomics, gene expression analysis in your target organism of choice, etc.

Aurora Fine Chemicals is a privately held company that was founded in 1990. As a chemicals R&D supplier we offer chemicals for R&D, drug discovery service, compound libraries and custom synthesis. We have one of the largest collections of 18.1 mln. chemicals available in stock and our docking software delivers hits/leads of very high quality in short time.

Our staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. In our Molecular Modeling Group are professionals specializing in computational drug design. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds. Aurora has significant expertise in synthesis of all types R&D chemicals for drug discovery like small molecules, natural products and peptides. Parallel synthesis with well-designed, targeted and fragment-based libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.

We own a large library of 18.1 million stocked compounds for R&D. Our substances are used in many research labs all over the world. We offer structures for biochemical and chemical research. Our products are applied in pharmaceutical development, diagnosis, and in chemical production.

Several laboratories for synthesis with modern equipment such as reactors, autoclaves, thermostats and hydrogenation equipment are available.

Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorption analysis and crystallographical methods.

The main advantage of Aurora's own software is the quality of the underlying physical models. Aurora's software derives molecular properties from first principles based on direct models using advanced quantum mechanical analysis of molecular interactions and thermodynamics.

We are a fresh and dynamic company providing the pharmaceutical and biotechnology sectors with a range of drug discovery solutions in the areas of organic, medicinal and computational chemistry.

Our highly professional and experienced team brings you a comprehensive range of both products and services to accelerate your drug discovery projects.

With exceptional experience in the operational management of drug discovery and custom synthesis projects, and able to offer a range of cost-effective business models, Avistron is ideally positioned to help you.

In addition to offering an attractive collection of synthetic heterocyclic building blocks and fragments, Avistron also offers bespoke services in the areas of intermediate, building block and final compound synthesis, having particular experience of diamine, piperazine mimetic and natural product-like compound synthesis.